Optimum Spray Congealing Conditions for Masking the Bitter Taste of Clarithromycin in Wax Matrix
スポンサーリンク
概要
- 論文の詳細を見る
The effects of operating conditions in the spray-congealing process on the release and the micromeritic properties of clarithromycin (CAM) wax matrix were evaluated. CAM wax matrix with 30% CAM, 60% glyceryl monostearate (GM) and 10% aminoalkyl methacrylate copolymer E (AMCE) was manufactured at various atomizer wheel speeds and liquid feed rates with a spray dryer. Release of CAM from the matrix exhibited a two-phase pattern, probably due to the dissolution of the fine portions broken on the surface of the matrix. The slope and the extrapolated y-intercept of the subsequent release pattern were defined as the release rate and the initial amount of release of CAM from the matrix, respectively. These release parameters, as well as the volume median diameter and the specific surface area of matrix, were selected as response variables, and multiple regression analysis was performed. For specific surface area and initial amount of release, a minimum point was observed on the contour curve when the atomizer wheel speed was constant and the liquid feed rate was varied. For the release rate, a maximum point was observed on the contour curve under the same conditions. These points were considered preferable for masking the bitter taste of CAM preparation. Microscopic observation revealed that a small spherical matrix with a smooth surface could be obtained with a high atomizer wheel spped and optimum liquid feed rate. This matrix also possessed excellent properties for taste masking, with small initial amount of release and subsequent high rate of release.In conclusion, the congealing speed of melt droplets was the dominant factor in masking the bitter taste of CAM.
- 公益社団法人日本薬学会の論文
- 1999-02-15
著者
-
Itai S
Pharmaceutics Laboratory Medicinal Research Laboratories Taisho Pharmaceutical Co. Ltd.
-
Yajima T
Pharmaceutics Laboratory Medicinal Research Laboratories Taisho Pharmaceutical Co. Ltd.
-
YAJIMA Toshio
Department of Pharmaceutics, Research Center, Taisho Pharmaceutical Co., Ltd.,
-
UMEKI Nobuo
Department of Pharmaceutics, Research Center, Taisho Pharmaceutical Co., Ltd.,
-
ITAI Shigeru
Department of Pharmaceutics, Research Center, Taisho Pharmaceutical Co., Ltd.,
-
Umeki N
Taisho Pharmaceutical Co. Ltd. Saitama Jpn
-
Yajima T
Department Of Pharmaceutics Research Center Taisho Pharmaceutical Co. Ltd.
-
Itai Shigeru
Department of Pharmaceutical Engineering, School of Pharmaceutical Sciences, University of Shizuoka
関連論文
- In Vitro Dissolution Tests Corresponding to the in Vivo Dissolution of Clarithromycin Tablets in the Stomach and Intestine
- A New Pharmacokinetic Model Including in Vivo Dissolution and Gastrointestinal Transit Parameters
- Direct Transport of 2', 3'-Didehydro-3'-deoxythymidine (D4T) and Its Ester Derivatives to the Cerebrospinal Fluid via the Nasal Mucous Membrane in Rats
- Nasal Absorption of 2', 3'-Didehydro-3'-deoxythymidine (D4T) and Its Esters in Rats
- Formulation Design of an Oral, Fast-Disintegrating Dosage Form Containing Taste-Masked Particles of Famotidine
- Formulation Design of Taste-Masked Particles, Including Famotidine, for an Oral Fast-Disintegrating Dosage Form
- Optimum Heat Treatment Conditions for Masking the Bitterness of the Clarithromycin Wax Matrix
- Determination of Optimum Processing Temperature for Transformation of Glyceryt Monostearate
- Method of Evaluation of the Bitterness of Clarithromycin Dry Syrup
- Optimum Spray Congealing Conditions for Masking the Bitter Taste of Clarithromycin in Wax Matrix
- Particle Design for Taste-Masking Using a Spray-Congealing Technique
- Determination of Useful Ranges of Mixing Conditions for Glycerin Fatty Acid Ester by Multiple Regression Analysis